CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer

NCT00129870 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

180

Enrollment

INDUSTRY

Sponsor class

Stopped Unplanned interim analysis by DSMB indicated possible reduced response rate with the addition of Ca/Mg in pooled population. Further analysis pending.

Conditions

Colorectal Cancer

Interventions

DRUG: oxaliplatin

Sponsor

Sanofi